A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
about
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)Chapter 11: Genome-wide association studiesRisk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyCancer pharmacogenomics: strategies and challengesInvestigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatmentCYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variantCytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsCardiovascular pharmacogenomics: current status and future directionsA conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomicsOverview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseasesPharmacogenomics discovery and implementation in genome-wide association studies eraInfluence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysisPharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonClinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementationEffects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysisWarfarin pharmacogenetics: does more accurate dosing benefit patients?Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityEffect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsWarfarin Pharmacogenetics: New Life for an Old DrugA genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin doseGenome-wide association study of paliperidone efficacyBiobanks and electronic medical records: enabling cost-effective researchGenotype imputationTranscriptomic analysis of autistic brain reveals convergent molecular pathologyGenetic factors associated with patient-specific warfarin dose in ethnic IndonesiansWarfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.Data-driven methods to discover molecular determinants of serious adverse drug events.10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosisAssessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.Integrating systems biology sources illuminates drug action.Pharmacogenetics and personal genomes.Pharmacogenetics of warfarin: challenges and opportunities.Applied pharmacogenomics in cardiovascular medicineGuided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants.Expectations, validity, and reality in pharmacogenetics.
P2860
Q21134099-06DFD2BF-7C56-44CC-81A5-00224AD07EA1Q21145310-C4C74DBE-5E85-4157-9C80-BEE3B987B267Q24289220-AD4D3ACC-BDB8-4340-BD1B-FD3255D21D01Q24289309-D7721B1B-00CB-41A9-8082-2DC89A3CFECBQ24310184-1642218E-0BF5-4A67-98D3-DE9D6C7ED052Q24322624-460686F4-C2D6-43CF-9519-DC2983C3995AQ24338572-8EB886A8-C825-494C-BB79-A96088D289E5Q26787099-90B3C5BF-C778-42F7-8AC8-0CE857AA94E1Q26801183-F7E4EFCE-1531-473C-8BC9-1DEF39949EDFQ26827814-C435C90F-9A0A-407C-84EF-4BA2C0B3F702Q26859589-F5A92C33-161B-4162-89DF-D1A9CB7E8585Q27001573-688DBE53-7AC6-4BDB-A1F3-6F5748C3DAA1Q27002899-4FEB79EE-3A78-4940-858C-C33584EEF559Q27006860-076BA333-EB85-4B15-994F-32878A193714Q27011524-0404BCA1-AF77-4443-AB11-34DED8F1DCC6Q27026134-24CB34EB-D2EE-46AC-AC06-A51CE1EA157DQ27027304-45D539C9-D4EC-4B8A-94B0-D0A991681761Q27334876-19A73348-61A2-4B75-BFB3-85826B0D37F5Q28083100-E9BFBC76-5420-4D5E-B7BF-3B2C6C6B74F2Q28276514-6D03832E-7B4E-4AFF-A367-870F4F925273Q28395337-FF2F4855-36C7-47D6-8977-A10BAF250A84Q28468726-70786708-49A9-45BA-984A-AA2C5AFB2B9BQ28475004-321EEF16-8E02-4C36-BD00-0590C2CA1856Q28587963-83F5EF15-6F0E-46A4-877C-148B32D2E0FAQ28652448-9AE61D63-6C9E-48B0-BDD4-07DC935189F2Q29614590-F7350EC2-0873-45BB-92CD-69FD99B1D502Q29614877-68DA0CCC-9CA5-4186-A617-F322453E9A1EQ31016306-310D16F4-C7AC-48FC-B585-557C41EAF26AQ31131437-FE0961B6-7C50-4650-8896-119629A76906Q33403734-96E24601-BBA8-46A3-AEC8-7D6E3F67A424Q33517162-D104D091-F469-4C08-AE1B-2FB696FB595AQ33579196-D7CDDD8B-7F28-4A44-B00E-B09E8191F4BBQ33644101-D0074C88-A6E3-427F-BFDD-FFD16933AB15Q33645618-B6FB5A27-0B3A-49E1-ACE0-2930793A3BBDQ33679969-43A36142-DBE4-4EE2-BDB3-49BCF2A3FB2AQ33819050-0E59682B-111B-4FBE-AAA2-9AD0686E62C0Q33846255-8E5B8AE0-8FB2-4FFD-A768-4CBE3932AA6DQ33863833-18D812AC-335C-47D1-B757-A30BB8DB05D6Q33921846-540D19CF-B4BD-4481-AD52-CE9CBDEAA499Q33926313-8AF287E8-7820-433E-A1C5-F0298E1C830F
P2860
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A genome-wide scan for common ...... e on warfarin maintenance dose
@en
type
label
A genome-wide scan for common ...... e on warfarin maintenance dose
@en
prefLabel
A genome-wide scan for common ...... e on warfarin maintenance dose
@en
P2093
P2860
P1433
P1476
A genome-wide scan for common ...... e on warfarin maintenance dose
@en
P2093
Allan E Rettie
C Michael Stein
Dan M Roden
David L Veenstra
Gregory M Cooper
Ian B Stanaway
Joshua D Smith
Julie A Johnson
Mark J Rieder
P2860
P304
P356
10.1182/BLOOD-2008-01-134247
P407
P577
2008-06-05T00:00:00Z